HOLON, Israel, March 12, 2019 /PRNewswire/ — Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company mp electricity bill payment online indore and leader in predictive target discovery, announced today that the United States Patent and Trademark Office (USPTO) has granted two composition of matter patents for COM701, the Company’s lead immuno-oncology therapeutic antibody candidate.
↧